SavedAdd your journal

Journals / Anadolu Tıp Dergisi / 2001 / Cilt: 3 - Sayı: 2

Sigara alışkanlığının tip 2 diabetes mellituslu hastalarda ve obezlerde HbAıC, fruktozamin, kolesterol ve lipit fraksiyonları düzeylerine etkisi

Effects of smoking on HbAıC, fructosamine, cholesterol and lipid fractions in diabetes mellitus type 2 and obesity

Ahmet ÇIĞLI
Mehmet TARAKÇIOĞLU
İclal MERAM
Pages
79–84
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In cases with DM type 2; FBG, TC, TG, LDL, fructosamine, HbAıC and ERF were elevated significantly (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aims of this study were to investigate the effects of smoking on Fasting Blood Glucose (FBG), Trygliceride (TG), Total Cholesterol (TC), High Density Lipoprotein (HDL), Low Density Lipoprotein (LDL), fructosamine and HbAıc levels and Establish Risk Factor (ERF) in DM type 2 and obesity in addition to overview the usefulness of different biochemical parameters in follow-up patients. 37 patients with DM, 50 cases with obesitywith Body Mass Index. (BMI) more than 25.95 and 43 healthy subject with BMI less than 25.95 have been included in the study.
📊
Key Findings & Data:All groups have been subdivided into smoker and non-smoker groups.
💡
Conclusion & Impact:In cases with DM type 2; FBG, TC, TG, LDL, fructosamine, HbAıC and ERF were elevated significantly (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The aims of this study were to investigate the effects of smoking on Fasting Blood Glucose (FBG), Trygliceride (TG), Total Cholesterol (TC), High Density Lipoprotein (HDL), Low Density Lipoprotein (LDL), fructosamine and HbAıc levels and Establish Risk Factor (ERF) in DM type 2 and obesity in addition to overview the usefulness of different biochemical parameters in follow-up patients. 37 patients with DM, 50 cases with obesitywith Body Mass Index. (BMI) more than 25.95 and 43 healthy subject with BMI less than 25.95 have been included in the study. All groups have been subdivided into smoker and non-smoker groups. In cases with DM type 2; FBG, TC, TG, LDL, fructosamine, HbAıC and ERF were elevated significantly (p

Özet

Bu çalışmada; sigaranın diyabet ve obezite üzerine etkisininin araştırılması amaçlandı. Ayrıca rutinde serum glukozu yerine tercih edilecek bazı testlerin daha güvenilir ve takip hastaları için tercih edilebileceği vurgulanmaya çalışıldı. Sigara içen ve içmeyen olmak üzere 37 Diabetes Mellitus'lu (DM) hastada ve 50 obez kişide bazı biyokimyasal parametreler çalışıldı. Kontrol grubu olarak Vücut Kitle İndeksi (VKİ) 25.95 den az olan sağlıklı kişiler alındı. DM'lu hastalarda açlık kan şekeri, total kolesterol, trigliserid, LDL, fruktozamin, glikozile hemoglobin (HbAı-c), Establish Risk Factor (ERF) kontrollere göre önemli bulundu (p

🔖

Cite This Article

ÇIĞLI, A., TARAKÇIOĞLU, M., MERAM, İ. (2022). Sigara alışkanlığının tip 2 diabetes mellituslu hastalarda ve obezlerde HbAıC, fruktozamin, kolesterol ve lipit fraksiyonları düzeylerine etkisi. Anadolu Tıp Dergisi, Cilt: 3 - Sayı: 2, 79–84. https://ajindex.com/articles/438169

References (15)

  1. Abrams JJ, Ginsberg H, Grundy SM:Metabolism of cholesterol and plasma triglycerides in nonketotic DM. Diabetes 1982;31: 903-10
  2. Albert KG, Boucher BJ, Hitman GA, et al. in:Cohen RD, Lewis B, Alberti KG, Denman AM,eds. The Metabolic and Moleculer Basis of Acuired Disease: Vol I. Phi: W.B. Saunders Co,1990; 801-25
  3. Baker JR, O'connor JP, Metcalf PA et al.Clinicalusefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus. Br Med J 1983; 287: 863-7
  4. Bermes EW, Young DS. General Laboratory Techniques and Procedures.In:Burtis CA,Ashwood ER, eds. Tıetz Textbook of Clinical Chemistry: WB Saunders Company, Philadelphia,1994;86
  5. Bouma M, Dekker JH, de Sonnaville JJ, et al.How valid is fasting plasma glucose as a parameterof glycemic control in non-insulin-using patients with type 2 diabetes? Diabetes Care 1999;22(6):904-7
  6. Brousolle C, Tricot F, Garsıo I, et al. Evaluation of the fructosamine test in obesity: cosequences for the assesment of past glycemic control in diabetes.Clinical Chemistry 1991;24:203-9
  7. CalbeathDF. Clinical Chemistry. A Fundamental Textbook, Phi: W.B.Saunders Company, 992: 294-6
  8. Cefalu WT, Parker TB, Jhonson CR: Validty ofserum fructosamine as index short term glycemic control in diabetic outpatients. Diabetes Care 1988;11(8): 662-8
  9. Destefano F, Ford ES, Newman J et al.: Risk factors for coronery heart disease mortality among personswith diabetes. Ann. Epidemiol 1993;3(l):27-34: 10. Deurenberg P, Westrtrate JA, Seidel JC. Body mass index as a measure of body fitness: Age and sex specific prediction formulas. British Journal of Nutrition. 1991;65: 105-114
  10. Dunn FL. Hyperlipidemia in diabetes mellitus.Diabetes Metb Reviews 1990; 1(6): 47-61
  11. Dunn FL. The Effects of diabetic control on VLDL trigliserid metabolism in patients with noninsulindependent DM. and hypertriglyceridemia. Metabolism 1984;33:117- 23
  12. Gedik O, Akalın S. Modern Tıp Seminerleri. In: Akalın S: Diabetes Mellitusun Kliniği. Ankara, Güneş Kitabevi, 1989; 1-10
  13. Gökbel H, Uysal H, Kaya A.Diyabetlilerde vücut kitle indeksi ve skinfold ölçümleri. Konya Selçuk Üniversitesi Tıp Fakültesi Dergisi. 1992; l(8):83-87
  14. Greenfield M, Kolterman O, Olefsky J, et al.: Mechanism of hypertriglyceridemia in diabetic patients with fasting hyperglycaemia. Diabetologia 1980; 18:441-46
  15. Halle M, Berg A, Garwers U, et al. Influence of 4 weeks intervention by exercise and diet on low-density lipoprotein subfra